Invitrogen

ADAM17 Polyclonal Antibody

1 Reference
View all (21) ADAM17 antibodies

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}

Datasheet
Protocols
Questions & Answers
Datasheet
Protocols
Questions & Answers
ADAM17 Polyclonal Antibody

Product Details

PA5-11572

Applications
Tested Dilution
Publications

Western Blot (WB)

1:1,000
View 1 publication 1 publication

Flow Cytometry (Flow)

1:10-1:50
-
Product Specifications

Species Reactivity

Human

Published species

Mouse

Host/Isotype

Rabbit / IgG

Class

Polyclonal

Type

Antibody

Immunogen

KLH conjugated synthetic peptide between 195-224 amino acids of human ADAM17
View immunogen

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

0.5 mg/mL

Purification

Protein A, Antigen affinity chromatography

Storage buffer

PBS, pH 7.4

Contains

0.09% sodium azide

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_2223542

Target Information

ADAM17 (disintegrin and metalloproteinase domain-containing protein 17) cleaves the membrane bound precusor of TNF-alpha to its mature soluble form. ADAM 17 is responsbile for the proteolytical release of soluble JAM3 from endothelial cells surface and the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1, and the amyloid precursor protein. It acts as an activator of the Notch pathway by mediating cleavage of Notch and generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT). Mutations in the gene can result in inflammatory skin and bowel disease, neonatal 1.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Bioinformatics

Protein Aliases: a disintegrin and metalloproteinase; ADAM; ADAM 17; ADAM metallopeptidase domain 18; ADAMs; CD156b; CD156b antigen; Disintegrin and metalloproteinase domain-containing protein 17; metalloendopeptidases; Snake venom-like protease; TNF-alpha convertase; TNF-alpha converting enzyme; TNF-alpha-converting enzyme; tumor necrosis factor, alpha, converting enzyme

View more View less

Gene Aliases: ADAM17; ADAM18; CD156B; CSVP; NISBD; NISBD1; TACE

View more View less

UniProt ID: (Human) P78536

View more View less

Entrez Gene ID: (Human) 6868

View more View less

Function(s)
metalloendopeptidase activity Notch binding interleukin-6 receptor binding integrin binding protein binding metallopeptidase activity zinc ion binding SH3 domain binding PDZ domain binding
Process(es)
response to hypoxia positive regulation of protein phosphorylation neutrophil mediated immunity germinal center formation positive regulation of leukocyte chemotaxis proteolysis membrane protein ectodomain proteolysis cell adhesion epidermal growth factor receptor signaling pathway Notch signaling pathway Notch receptor processing positive regulation of cell proliferation positive regulation of T cell chemotaxis B cell differentiation positive regulation of cell growth positive regulation of cell migration positive regulation of transforming growth factor beta receptor signaling pathway negative regulation of transforming growth factor beta receptor signaling pathway membrane protein intracellular domain proteolysis positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle response to lipopolysaccharide positive regulation of chemokine production regulation of mast cell apoptotic process T cell differentiation in thymus tumor necrosis factor-mediated signaling pathway cell adhesion mediated by integrin wound healing, spreading of epidermal cells epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway response to drug positive regulation of epidermal growth factor-activated receptor activity spleen development cell motility defense response to Gram-positive bacterium PMA-inducible membrane protein ectodomain proteolysis positive regulation of cellular component movement response to high density lipoprotein particle
guarantee_icon

Performance Guarantee

If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*

Learn more
help_icon

We're here to help

Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.

Contact tech support